AI Terminal
Carl Zeiss Meditec AG
M&A Activity • Oct 23, 2018
74_rns_2018-10-23_ec8b8066-2129-4dac-91de-34e29102b6c1.html
M&A Activity
Open in ViewerOpens in native device viewer
News Details
Corporate | 23 October 2018 18:00
Carl Zeiss Meditec to Acquire IanTECH, Inc. to expand its portfolio in cataract surgery
DGAP-News: Carl Zeiss Meditec AG / Key word(s): Takeover
23.10.2018 / 18:00
The issuer is solely responsible for the content of this announcement.
| Carl Zeiss Meditec to Acquire IanTECH, Inc. to expand its portfolio in cataract surgery |
| ZEISS to enhance its portfolio of Surgical Ophthalmology solutions, further positioning the Company as a global innovation leader and solution provider in the full space of ophthalmology. |
JENA/GERMANY, October 23, 2018.
Carl Zeiss Meditec today announced it has entered into an agreement to acquire IanTECH. Headquartered in Reno, Nevada, IanTECH is a privately held company focused on technology solutions for micro-interventional cataract surgery.
Cataract surgery has been dependent on phaco technology for over 50 years. ZEISS believes that the market needs a fresh innovative approach in the field of phaco. IanTECH’s surgical technology is designed to change the future of managing cataracts. “We expect that IanTECH will complement our leading portfolio of equipment and consumables in cataract surgery, allowing us to offer physicians and patients a new standard of care,” says Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec. “The technology has the potential to simplify challenging cases, reduce risk to patients and further improve outcomes while being easy to train and adapt for surgeons.”
“We are pleased to bring the IanTECH team and technology into the ZEISS family,” states James V. Mazzo, Global President Ophthalmic Devices at Carl Zeiss Meditec.
“We look forward to joining ZEISS to combine our efforts in bringing superior technology to the market and we are pleased to align with the great culture and commitment at ZEISS,” adds Brian Walsh, CEO of IanTECH.
Contact for the press
Laurie Ferguson
Head of OPT Global Communications
Phone: +1 925 560 5163
Email: [email protected]
Contact for investors
Sebastian Frericks
Director Investor Relations Carl Zeiss Meditec AG
Phone: +49 3641 220-106
Email: [email protected]
23.10.2018 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | Carl Zeiss Meditec AG |
| Göschwitzer Str. 51-52 | |
| 07745 Jena | |
| Germany | |
| Phone: | +49 (0)3641 220-0 |
| Fax: | +49 (0)3641 220-112 |
| E-mail: | [email protected] |
| Internet: | www.zeiss.de/meditec-ag/ir |
| ISIN: | DE0005313704 |
| WKN: | 531370 |
| Indices: | SDAX, TecDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| End of News | DGAP News Service |